Effect of Potassium Citrate Therapy on the Risk of Renal Stone Formation During Spaceflight

Journal of Urology

Volumn 182, Issue 5, 2009, Pages 2490-2496

  Whitson, Peggy A ^a   Pietrzyk, Robert A ^c   Jones, Jeffrey A ^a   Nelman Gonzalez, Mayra ^c   Hudson, Edgar K ^b   Sams, Clarence F ^a  

^a NASA JOHNSON SPACE CENTER   (United States)

^b JES Tech   (United States)

^c WYLE LABORATORIES   (United States)

Author keywords

kidney; kidney calculi; potassium citrate; space flight; uric acid

Indexed keywords

CALCIUM; CALCIUM OXALATE; CITRATE POTASSIUM; PLACEBO;

ADULT; ARTICLE; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COSMONAUT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SPACE FLIGHT; STONE FORMATION; URIC ACID STONE; URINALYSIS; URINE PH; RISK FACTOR;

ADULT; FEMALE; HUMANS; KIDNEY CALCULI; MALE; POTASSIUM CITRATE; RISK FACTORS; SPACE FLIGHT;

EID: 70350445145     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.010     Document Type: Article

References (14)

1. Pietrzyk R.A., Jones J.A., Sams C.F., et al. Renal stone formation among astronauts. Aviat Space Environ Med 78 suppl. (2007) A9
2. Whitson P.A., Pietrzyk R.A., Morukov B.V., et al. The risk of renal stone formation during and after long duration space flight. Nephron 89 (2001) 264
3. Whitson P., Pietrzyk R., Pak C., et al. Alterations in renal stone risk factors after space flight. J Urol 150 (1993) 803
4. Nicar M.J., Hsu M.C., Johnson T., et al. The preservation of urine samples for determination of renal stone risk factors. Lab Med 18 (1987) 382
5. Finlayson B. Calcium stones: some physical and clinical aspects. In: David D.S. (Ed). Calcium Metabolism in Renal Failure and Nephrolithiasis (1977), John Wiley & Sons, New York 337
6. Pak C.Y. Pharmacotherapy of kidney stones. Expert Opin Pharmacother 9 (2008) 1509
7. Whalley N.A., Meyers A.M., Martins M., et al. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 78 (1996) 10
8. Curhan G.C., and Curhan S.G. Dietary factors and kidney stone formation. Compr Ther 20 (1994) 485
9. Morton A.R., Iliescu E.A., and Wilson J.W.L. Neprology: 1. Investigation and treatment of recurrent kidney stones. CMAJ 166 (2002) 213
10. Jones J.A., Johnston S., Campbell M., et al. Endoscopic surgery and telemedicine in microgravity: developing contingency procedures for exploratory class spaceflight. Urology 53 (1999) 892
11. Zerwekh J.E., Odvina C.V., Wuermser L.A., et al. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol 177 (2007) 2179
12. Ettinger B., Pak C.Y., Citron J.T., et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158 (1997) 2069
13. Hamm L.L. Renal handling of citrate. Kidney Int 38 (1990) 728
14. Caudarell R., Vescini F., Buffa A., et al. Citrate and mineral metabolism: kidney stones and bone disease. Frontiers Biosci 8 (2003) 1084